C125H166F21N43O14S7 — CID 159778806
3-[4-[2-(1-aminocyclopropyl)ethyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)piperidin-1-yl]-2-(4H-triazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-9-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;bis(3-(4-piperidin-4-ylcyclohexyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide) (PubChem CID 159778806) has the molecular formula C125H166F21N43O14S7 and a molecular weight of 3118.42 g/mol. Its IUPAC name is 3-[4-[2-(1-aminocyclopropyl)ethyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)piperidin-1-yl]-2-(4H-triazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-9-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;bis(3-(4-piperidin-4-ylcyclohexyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide).
| Compound Name | 3-[4-[2-(1-aminocyclopropyl)ethyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)piperidin-1-yl]-2-(4H-triazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-9-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;bis(3-(4-piperidin-4-ylcyclohexyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide) |
|---|---|
| PubChem CID | 159778806 |
| Molecular Formula | C125H166F21N43O14S7 |
| Molecular Weight | 3118.42 g/mol |
| Exact Mass | 3116.13 |
| IUPAC Name | 3-[4-[2-(1-aminocyclopropyl)ethyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethylamino)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(3-aminopropyl)piperidin-1-yl]-2-(4H-triazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(3-azaspiro[5.5]undecan-9-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;bis(3-(4-piperidin-4-ylcyclohexyl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide) |
| SMILES | NC1(CCC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCCC1CCC(c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2-c2nn[nH]n2)CC1.NCCCC1CCN(c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2C2=NN=NC2)CC1.NCCNC1CCC(c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2-c2nn[nH]n2)CC1.NS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(C3CCNCC3)CC2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(C3CCNCC3)CC2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC3(CCNCC3)CC2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/3C19H25F3N6O2S.C18H23F3N6O2S.2C17H23F3N6O2S.C16H22F3N7O2S/c2*20-19(21,22)15-6-5-14(16(17(15)31(23,29)30)18-25-27-28-26-18)13-3-1-11(2-4-13)12-7-9-24-10-8-12;20-19(21,22)14-6-5-13(15(16(14)31(24,29)30)17-25-27-28-26-17)12-3-1-11(2-4-12)7-8-18(23)9-10-18;19-18(20,21)13-2-1-12(11-3-5-17(6-4-11)7-9-23-10-8-17)14(15(13)30(22,28)29)16-24-26-27-25-16;18-17(19,20)13-8-7-12(11-5-3-10(4-6-11)2-1-9-21)14(15(13)29(22,27)28)16-23-25-26-24-16;18-17(19,20)12-3-4-14(26-8-5-11(6-9-26)2-1-7-21)15(13-10-23-25-24-13)16(12)29(22,27)28;17-16(18,19)12-6-5-11(9-1-3-10(4-2-9)22-8-7-20)13(14(12)29(21,27)28)15-23-25-26-24-15/h2*5-6,11-13,24H,1-4,7-10H2,(H2,23,29,30)(H,25,26,27,28);5-6,11-12H,1-4,7-10,23H2,(H2,24,29,30)(H,25,26,27,28);1-2,11,23H,3-10H2,(H2,22,28,29)(H,24,25,26,27);7-8,10-11H,1-6,9,21H2,(H2,22,27,28)(H,23,24,25,26);3-4,11H,1-2,5-10,21H2,(H2,22,27,28);5-6,9-10,22H,1-4,7-8,20H2,(H2,21,27,28)(H,23,24,25,26) |
| InChIKey | NHCBNAMMZXWBTE-UHFFFAOYSA-N |
| XLogP | 17.38 |
| TPSA | 940.40 Ų |
| H-Bond Donors | 21 |
| H-Bond Acceptors | 44 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 210 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3118.42 |
| LogP ≤ 5 | 17.38 |
| H-Bond Donors ≤ 5 | 21 |
| H-Bond Acceptors ≤ 10 | 44 |